Crossed cerebellar diaschisis (CCD) is associated with poorer stroke outcome and is traditionally measured with [15O]-H2O-PET.
BOLD-CVR can detect CCD with high specificity and sensitivity. Furthermore, CCD subjects identified with BOLD-CVR also had a poorer clinical status at baseline and at three months follow-up. These encouraging results suggest that BOLD-CVR might be considered as a diagnostic and prognostic test for CCD subjects, comparable to the gold standard [15O]-H2O-PET – but without the ~1mSv radiation dose.
This abstract and the presentation materials are available to members only; a login is required.